Injectable Anticoagulants Market Trends, Growth Analysis, Investigation by Regions, Types, Applications and Analysis of Key Players

The QY Research released a latest market research report on the Global Injectable Anticoagulants market, which is segmented by region (country), company and by Application. Players, stakeholders, and other participants in the global Injectable Anticoagulants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application of Global Injectable Anticoagulants market.

For More Information About This Report, Please Enter:

https://us.qyresearch.com/reports/348700/injectable-anticoagulants

Summary

The global Injectable Anticoagulants market size is projected to reach US$ 9907.8 million by 2028, from US$ 6667.5 million in 2021, at a CAGR of 5.60% during 2022-2028.

Low-Molecular-Weight Heparin (LMWH) accounting for 50.07% of the Injectable Anticoagulants global market in 2021, is projected to value US$ 5353.2 million by 2028, growing at a revised 6.64% CAGR in the forecast period. While VTE segment is altered to a 5.51% CAGR throughout this forecast period.

China Injectable Anticoagulants market size is valued at US$ 1102.7 million in 2021, while the North America and Europe Injectable Anticoagulants are US$ 2111.3 million and US$ 2283.7 million, severally. The proportion of the North America is 31.67% in 2021, while China and Europe are 16.54% and 34.25% respectively, and it is predicted that China proportion will reach 24.13% in 2028, trailing a CAGR of 11.44% through the analysis period. As for the Europe Injectable Anticoagulants landscape, Germany is projected to reach US$ 680.3 million by 2028 trailing a CAGR of 2.55% over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injectable Anticoagulants market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injectable Anticoagulants market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injectable Anticoagulants market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injectable Anticoagulants market.

The report mentions the prominent market player consisting of:

Sanofi

Genentech (Roche)

Boehringer Ingelheim

Aspen

Pfizer

Hepalink

King-friend

CSBIO

Amphastar Pharmaceuticals

Injectable Anticoagulants Market Segment by Type

LMWH

Unfractionated Heparin

Fibrinolytics

Other

Injectable Anticoagulants Market Segment by Application

VTE

ACS/MI

AF

Other

The report on the Injectable Anticoagulants market covers the following region (country) analysis:

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Europe

Germany

France

U.K.

Italy

Russia

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

GCC

Turkey

South Africa

Rest of MEA

 

The Goal of the Report

To study and analyze the global Injectable Anticoagulantsconsumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Injectable Anticoagulantsmarket by identifying its various subsegments.
Focuses on the key global Injectable Anticoagulantsmanufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Injectable Anticoagulantswith respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Injectable Anticoagulantssubmarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Target Audience

> Injectable Anticoagulants companies

> Research organizations

> Government Organizations

> Research/Consultancy firms

Table of Contents

 

1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Injectable Anticoagulants Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1
1.2.2 Low-Molecular-Weight Heparin (LMWH) 2
1.2.3 Unfractionated Heparin 2
1.2.4 Fibrinolytics 2
1.2.5 Other 3
1.3 Market by Application 3
1.3.1 Global Injectable Anticoagulants Market Share by Application: 2017 VS 2021 VS 2028 3
1.3.2 AF 4
1.3.3 VTE 4
1.3.4 ACS/MI 4
1.4 Study Objectives 4
1.5 Years Considered 5

2 GLOBAL GROWTH TRENDS 6
2.1 Global Injectable Anticoagulants Market Perspective (2017-2028) 6
2.2 Injectable Anticoagulants Growth Trends by Region 7
2.2.1 Injectable Anticoagulants Market Size by Region: 2017 VS 2021 VS 2028 7
2.2.2 Injectable Anticoagulants Historic Market Size by Region (2017-2022) 7
2.2.3 Injectable Anticoagulants Forecasted Market Size by Region (2023-2028) 8
2.3 Injectable Anticoagulants Market Dynamics 9
2.3.1 Injectable Anticoagulants Industry Trends 9
2.3.2 Injectable Anticoagulants Market Drivers 9
2.3.3 Injectable Anticoagulants Market Challenges 10
2.4 Prevalence and Incident Rate of Thrombosis and Protein C/S Deficiency 10

3 COMPETITION LANDSCAPE BY KEY PLAYERS 11
3.1 Global Top Injectable Anticoagulants Players by Revenue 11
3.1.1 Global Top Injectable Anticoagulants Players by Revenue (2017-2022) 11
3.1.2 Global Injectable Anticoagulants Revenue Market Share by Players (2017-2022) 12
3.2 Players Covered: Ranking by Injectable Anticoagulants Revenue 13
3.3 Global Injectable Anticoagulants Market Concentration Ratio 14
3.3.1 Global Injectable Anticoagulants Market Concentration Ratio (CR5) 14
3.3.2 Global Top 3 and Top 5 Companies by Injectable Anticoagulants Revenue in 2021 15
3.4 Injectable Anticoagulants Key Players Head office and Area Served 16
3.5 Key Players Injectable Anticoagulants Product Solution and Service 16
3.6 Establish Date of Injectable Anticoagulants Players 16
3.7 Mergers & Acquisitions, Expansion Plans 17

4 INJECTABLE ANTICOAGULANTS BREAKDOWN DATA BY TYPE 18
4.1 Global Injectable Anticoagulants Historic Market Size by Type (2017-2022) 18
4.2 Global Injectable Anticoagulants Forecasted Market Size by Type (2023-2028) 19

5 INJECTABLE ANTICOAGULANTS BREAKDOWN DATA BY APPLICATION 20
5.1 Global Injectable Anticoagulants Historic Market Size by Application (2017-2022) 20
5.2 Global Injectable Anticoagulants Forecasted Market Size by Application (2023-2028) 21

6 NORTH AMERICA 22
6.1 North America Injectable Anticoagulants Market Size (2017-2028) 22
6.2 North America Injectable Anticoagulants Market Size by Country (2017-2022) 22
6.3 North America Injectable Anticoagulants Market Share by Country (2023-2028) 23
6.4 United States 23
6.5 Canada 24

7 EUROPE 25
7.1 Europe Injectable Anticoagulants Market Size (2017-2028) 25
7.2 Europe Injectable Anticoagulants Market Size by Country (2017-2022) 25
7.3 Europe Injectable Anticoagulants Market Size by Country (2023-2028) 26
7.4 Germany 26
7.5 France 27
7.6 U.K. 27
7.7 Italy 28
7.8 Russia 28

8 ASIA-PACIFIC 29
8.1 Asia-Pacific Injectable Anticoagulants Market Size (2017-2028) 29
8.2 Asia-Pacific Injectable Anticoagulants Market Size by Region (2017-2022) 29
8.3 Asia-Pacific Injectable Anticoagulants Market Size by Region (2023-2028) 30
8.4 China 30
8.5 Japan 31
8.6 South Korea 31
8.7 Southeast Asia 32
8.8 India 32
8.9 Australia 33

9 LATIN AMERICA 34
9.1 Latin America Injectable Anticoagulants Market Size (2017-2028) 34
9.2 Latin America Injectable Anticoagulants Market Size by Country (2017-2022) 34
9.3 Latin America Injectable Anticoagulants Market Size by Country (2023-2028) 35
9.4 Mexico 35
9.5 Brazil 36

10 MIDDLE EAST & AFRICA 37
10.1 Middle East & Africa Injectable Anticoagulants Market Size (2017-2028) 37
10.2 Middle East & Africa Injectable Anticoagulants Market Size by Country (2017-2022) 37
10.3 Middle East & Africa Injectable Anticoagulants Market Size by Country (2023-2028) 38
10.4 Turkey 38
10.5 GCC 39
10.6 South Africa 39

11 KEY PLAYERS PROFILES 40
11.1 Sanofi 40
11.1.1 Sanofi Company Details 40
11.1.2 Sanofi Business Overview 40
11.1.3 Sanofi Injectable Anticoagulants Introduction 41
11.1.4 Sanofi Revenue in Injectable Anticoagulants Business (2017-2022) 41
11.2 Genentech (Roche) 42
11.2.1 Genentech (Roche) Company Details 42
11.2.2 Genentech (Roche) Business Overview 42
11.2.3 Genentech (Roche) Injectable Anticoagulants Introduction 43
11.2.4 Genentech (Roche) Revenue in Injectable Anticoagulants Business (2017-2022) 43
11.3 Boehringer Ingelheim 43
11.3.1 Boehringer Ingelheim Company Details 44
11.3.2 Boehringer Ingelheim Business Overview 44
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Introduction 44
11.3.4 Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2017-2022) 45
11.4 Aspen 45
11.4.1 Aspen Company Details 45
11.4.2 Aspen Business Overview 46
11.4.3 Aspen Injectable Anticoagulants Introduction 46
11.4.4 Aspen Revenue in Injectable Anticoagulants Business (2017-2022) 47
11.5 Pfizer 47
11.5.1 Pfizer Company Details 47
11.5.2 Pfizer Business Overview 48
11.5.3 Pfizer Injectable Anticoagulants Introduction 48
11.5.4 Pfizer Revenue in Injectable Anticoagulants Business (2017-2022) 49
11.6 Hepalink 49
11.6.1 Hepalink Company Details 49
11.6.2 Hepalink Business Overview 49
11.6.3 Hepalink Injectable Anticoagulants Introduction 50
11.6.4 Hepalink Revenue in Injectable Anticoagulants Business (2017-2022) 51
11.7 King-friend 51
11.7.1 King-friend Company Details 51
11.7.2 King-friend Business Overview 51
11.7.3 King-friend Injectable Anticoagulants Introduction 52
11.7.4 King-friend Revenue in Injectable Anticoagulants Business (2017-2022) 53
11.8 CSBIO 53
11.8.1 CSBIO Company Details 53
11.8.2 CSBIO Business Overview 53
11.8.3 CSBIO Injectable Anticoagulants Introduction 54
11.8.4 CSBIO Revenue in Injectable Anticoagulants Business (2017-2022) 54
11.9 Amphastar Pharmaceuticals 54
11.9.1 Amphastar Pharmaceuticals Company Details 55
11.9.2 Amphastar Pharmaceuticals Business Overview 55
11.9.3 Amphastar Pharmaceuticals Injectable Anticoagulants Introduction 56
11.9.4 Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2017-2022) 56

12 ANALYST'S VIEWPOINTS/CONCLUSIONS 57

13 APPENDIX 58
13.1 Research Methodology 58
13.1.1 Methodology/Research Approach 58
13.1.2 Data Source 61
13.2 Disclaimer 64

Access full Report Description, Table of Figure, Chart, FREE sample, etc. please click 

https://us.qyresearch.com/reports/348700/injectable-anticoagulants

Any doubts and questions will be welcome.

Customization of the Report:

This report can be customized to meet the client's requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.

About Us:

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

Contact Us

QY Research

E-mail: global@qyresearch.com

Tel: +1-626-842-1666(US)   +852-5808-0956 (HK)

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

Website: https://us.qyresearch.com

The QY Research released a latest market research report on the Global Injectable Anticoagulants market, which is segmented by region (country), company and by Application. Players, stakeholders, and other participants in the global Injectable Anticoagulants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application of Global Injectable Anticoagulants market.

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

This release was published on openPR.